These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 33315227)

  • 21. Recent computational advances in the identification of allosteric sites in proteins.
    Lu S; Huang W; Zhang J
    Drug Discov Today; 2014 Oct; 19(10):1595-600. PubMed ID: 25107670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A molecular dynamics investigation of CDK8/CycC and ligand binding: conformational flexibility and implication in drug discovery.
    Cholko T; Chen W; Tang Z; Chang CA
    J Comput Aided Mol Des; 2018 Jun; 32(6):671-685. PubMed ID: 29737445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploiting protein flexibility to predict the location of allosteric sites.
    Panjkovich A; Daura X
    BMC Bioinformatics; 2012 Oct; 13():273. PubMed ID: 23095452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1.
    Ferraro M; Moroni E; Ippoliti E; Rinaldi S; Sanchez-Martin C; Rasola A; Pavarino LF; Colombo G
    J Phys Chem B; 2021 Jan; 125(1):101-114. PubMed ID: 33369425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of molecular dynamics simulation in biomedicine.
    Wu X; Xu LY; Li EM; Dong G
    Chem Biol Drug Des; 2022 May; 99(5):789-800. PubMed ID: 35293126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revealing the Positive Binding Cooperativity Mechanism between the Orthosteric and the Allosteric Antagonists of CCR2 by Metadynamics and Gaussian Accelerated Molecular Dynamics Simulations.
    An X; Bai Q; Bing Z; Liu H; Zhang Q; Liu H; Yao X
    ACS Chem Neurosci; 2020 Feb; 11(4):628-637. PubMed ID: 31968162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allostery in G protein-coupled receptors investigated by molecular dynamics simulations.
    Lamim Ribeiro JM; Filizola M
    Curr Opin Struct Biol; 2019 Apr; 55():121-128. PubMed ID: 31096158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced Sampling Applied to Modeling Allosteric Regulation in Transcription.
    Wang Y; Brooks CL
    J Phys Chem Lett; 2019 Oct; 10(19):5963-5968. PubMed ID: 31535860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular dynamics simulations and novel drug discovery.
    Liu X; Shi D; Zhou S; Liu H; Liu H; Yao X
    Expert Opin Drug Discov; 2018 Jan; 13(1):23-37. PubMed ID: 29139324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping the druggable allosteric space of G-protein coupled receptors: a fragment-based molecular dynamics approach.
    Ivetac A; McCammon JA
    Chem Biol Drug Des; 2010 Sep; 76(3):201-17. PubMed ID: 20626410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allosteric sites can be identified based on the residue-residue interaction energy difference.
    Ma X; Qi Y; Lai L
    Proteins; 2015 Aug; 83(8):1375-84. PubMed ID: 25185787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allo-network drugs: extension of the allosteric drug concept to protein- protein interaction and signaling networks.
    Szilágyi A; Nussinov R; Csermely P
    Curr Top Med Chem; 2013; 13(1):64-77. PubMed ID: 23409766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How Effectively Can Adaptive Sampling Methods Capture Spontaneous Ligand Binding?
    Betz RM; Dror RO
    J Chem Theory Comput; 2019 Mar; 15(3):2053-2063. PubMed ID: 30645108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating Small-Molecule Ligand Binding to G Protein-Coupled Receptors with Biased or Unbiased Molecular Dynamics Simulations.
    Marino KA; Filizola M
    Methods Mol Biol; 2018; 1705():351-364. PubMed ID: 29188572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms for allosteric activation of protease DegS by ligand binding and oligomerization as revealed from molecular dynamics simulations.
    Lu C; Stock G; Knecht V
    Proteins; 2016 Nov; 84(11):1690-1705. PubMed ID: 27556733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic Docking: A Paradigm Shift in Computational Drug Discovery.
    Gioia D; Bertazzo M; Recanatini M; Masetti M; Cavalli A
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29165360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation Between Allosteric and Orthosteric Sites.
    Zhang W; Xie J; Lai L
    Adv Exp Med Biol; 2019; 1163():89-105. PubMed ID: 31707701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solvents to Fragments to Drugs: MD Applications in Drug Design.
    Defelipe LA; Arcon JP; Modenutti CP; Marti MA; Turjanski AG; Barril X
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30544890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of potential allosteric binding sites in cathepsin K based on intramolecular communication.
    Rocha GV; Bastos LS; Costa MGS
    Proteins; 2020 Dec; 88(12):1675-1687. PubMed ID: 32683717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging Methods and Applications to Decrypt Allostery in Proteins and Nucleic Acids.
    Arantes PR; Patel AC; Palermo G
    J Mol Biol; 2022 Sep; 434(17):167518. PubMed ID: 35240127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.